References
- Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W. Adult acute myeloid leukaemia. Grit Rev Oncol Hematol 2004; 50(3):197–222.
- Bruserud O, Wendelboe O. Biological treatment in acute myelo-genous leukaemia: how should T-cell targeting immunotherapy be combined with intensive chemotherapy? Expert Opin Biol Ther 2001; 1(6): 1005–1016.
- Hatfield KJ, Olsnes AM, Gjertsen BT, Bruserud O. Antiangiogenictherapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileu-kemic strategies. Curr Cancer Drug Targets 2005; 5(4):229–248.
- Moser B, Loetscher P. Lymphocyte traffic control by chemokines.Nature Immunol 2001; 2(2): 123–128.
- Bruserud O, Ryningen A, Olsnes AM et al. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica 2007; 92(3): 332–341.
- Bruserud O, Tronstad KJ, Berge R. In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum. J. Cancer Res Clin Oncol 2005; 131(6): 377–384.
- Lippert U, Zachmann K, Henz BM, Neumann C. Human T lymphocytes and mast cells differentially express and regulate extra- and intracellular CXCR1 and CXCR2. Exp Dermatol 2004; 13(8): 520–525.
- Balkwill F. Cancer and the chemokine network. Nature Rev 2004;4(7): 540–550.
- Anensen N, Oyan AM, Bourdon JC, Kalland KH, Bruserud O, Gjertsen BT. A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clin Cancer Res 2006; 12(13): 3985–3892.
- Irish JM, Anensen N, Hovland R et al. F1t3 Y591 duplication and Bc1-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood 2007; 109(6): 2589–2596.
- Bruserud O, Ehninger G, Hamann W, Pawelec G. Secretion of IL-2, IL-3, IL-4, IL-6 and GM-CSF by CD4 + and CD8+ TCR alpha beta+ T-cell clones derived early after allogeneic bone marrow transplantation. Scand J Immunol 1993; 38(1): 65–74.
- Bruserud O. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; character-ization of the cytokine repertoire of clonogenic T cells. Cancer Immunol Immunother 1998; 46(4): 221–228.